(1) Describe longitudinal trends in annual prevalence of hospital admission for pediatric acute otitis media (AOM) and complications of AOM (CAOM) since introduction of pneumococcal vaccination in 2000 and (2) describe the longitudinal trend of prevalence of hospital admission for pneumococcal meningitis in children with AOM-related diagnoses in the postvaccination era.
Study Design
Retrospective analysis of Kids’ Inpatient Database from 2000 to 2012.
Setting
Community, nonrehabilitation hospitals.
Subjects and Methods
To determine annual prevalence of admission for AOM/CAOM, nationally weighted frequencies of children aged <21 years with acute suppurative otitis media, acute mastoiditis, suppurative labyrinthitis, and/or acute petrositis were collected. The frequency of coexisting pneumococcal meningitis diagnoses among these patients was also collected. Trend analysis of prevalences of admission for AOM/CAOM and for pneumococcal meningitis occurring in the setting of AOM/CAOM from 2000 to 2012 was performed.
Results
Between 2000 and 2012, annual prevalence of admission for AOM/CAOM decreased from 3.956 to 2.618 per 100,000 persons (P < .0001) (relative risk reduction 34%). Declines in admission prevalence were most pronounced in children <1 year of age (from 22.647 to 8.715 per 100,000 persons between 2000 and 2012, P < .0001) and 1 to 2 years of age (from 13.652 to 5.554 per 100,000 persons between 2000 and 2012, P < .0001). For all ages, the admission prevalence for pneumococcal meningitis and concomitant AOM/CAOM decreased (from 1.760 to 0.717 per 1,000,000 persons, P < .0001) over the study period.
Conclusions
The prevalence of hospital admission for pediatric AOM/CAOM has declined since the advent of pneumococcal vaccination. Admission rates for pneumococcal meningitis with AOM/CAOM have similarly declined.
GrijalvaCGNuortiJPGriffinMR.Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA. 2009;302:758-766.
2.
McCaigLFBesserREHughesJM.Trends in antimicrobial prescribing rates for children and adolescents. JAMA. 2002;287:3096-3102.
3.
Centers for Disease Control and Prevention (CDC). Recommended childhood immunization schedule—United States, 2001. MMWR Morb Mortal Wkly Rep. 2001;50:7-10, 19.
4.
BlackSShinefieldHFiremanB. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000;19:187-195.
5.
EskolaJKilpiTPalmuA. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:403-409.
6.
ZhouFSheferAKongYNuortiJP.Trends in acute otitis media–related health care utilization by privately insured young children in the United States, 1997-2004. Pediatrics. 2008;121:253-260.
7.
McEllistremMCAdamsJMPatelK. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2005;40:1738-1744.
8.
CaseyJRAdlowitzDGPichicheroME.New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2010;29:304-309.
9.
Centers for Disease Control and Prevention (CDC). Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children—Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep. 2010;59:258-261.
10.
MaromTTanAWilkinsonGSPiersonKSFreemanJLChonmaitreeT.Trends in otitis media-related health care use in the United States, 2001-2011. JAMA Pediatr. 2014;168:68-75.
11.
RoddyMGGlazierSSAgrawalD.Pediatric mastoiditis in the pneumococcal conjugate vaccine era: symptom duration guides empiric antimicrobial therapy. Pediatr Emerg Care. 2007;23:779-784.
12.
ChoiSSLanderL.Pediatric acute mastoiditis in the post-pneumococcal conjugate vaccine era. Laryngoscope. 2011;121:1072-1080.
13.
GiannakopoulosPChrysovergisAXirogianniA. Microbiology of acute mastoiditis and complicated or refractory acute otitis media among hospitalized children in the postvaccination era. Pediatr Infect Dis J. 2014;33:111-113.
14.
DanielMGautamSScrivenerTAMellerCLevinBCurottaJ.What effect has pneumococcal vaccination had on acute mastoiditis?J Laryngol Otol. 2013;127:S30-S34.
15.
QuesnelSNguyenMPierrotSContencinPManachYCouloignerV.Acute mastoiditis in children: a retrospective study of 188 patients. Int J Pediatr Otorhinolaryngol. 2010;74:1388-1392.
16.
PritchettCVThorneMC.Incidence of pediatric acute mastoiditis: 1997-2006. Arch Otolaryngol Head Neck Surg. 2012;138:451-455.
TeeleDWKleinJORosnerB.Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis. 1989;160:83-94.
19.
ParadiseJLRocketteHEColbornDK. Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics. 1997;99:318-333.
20.
LadomenouFKafatosATselentisYGalanakisE.Predisposing factors for acute otitis media in infancy. J Infect. 2010;61:49-53.
21.
ChonmaitreeTTrujilloRJenningsK. Acute otitis media and other complications of viral respiratory infection [published online March28, 2016]. Pediatrics.
22.
PoehlingKALafleurBJSzilagyiPG. Population-based impact of pneumococcal conjugate vaccine in young children. Pediatrics. 2004;114:755-761.
23.
PumarolaFMarèsJLosadaI. Microbiology of bacteria causing recurrent acute otitis media (AOM) and AOM treatment failure in young children in Spain: shifting pathogens in the post-pneumococcal conjugate vaccine era. Int J Pediatr Otorhinolaryngol. 2013;77:1231-1236.
24.
AhnJHKimM-NSukYAMoonBJ.Preoperative, intraoperative, and postoperative results of bacterial culture from patients with chronic suppurative otitis media. Otol Neurotol. 2012;33:54-59.
25.
LeeSKParkDCKimMG. Rate of isolation and trends of antimicrobial resistance of multidrug resistant Pseudomonas aeruginosa from otorrhea in chronic suppurative otitis media. Clin Exp Otorhinolaryngol. 2012;5:17-22.
26.
AlbertRRJobAKuruvillaGJosephRBrahmadathanKNJohnA.Outcome of bacterial culture from mastoid granulations: is it relevant in chronic ear disease?J Laryngol Otol. 2005;119:774-778.
27.
ChangJLeeSHChoiJImGJJungHH.Nasopharynx as a microbiologic reservoir in chronic suppurative otitis media: preliminary study. Clin Exp Otorhinolaryngol. 2011;4:122-125.
28.
OngkasuwanJValdezTAHultenKGMasonEOJrKaplanSL.Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates. Pediatrics. 2008;122:34-39.
29.
WallsAPierceMKrishnanNSteehlerMHarleyEHJr.Pediatric head and neck complications of Streptococcus pneumoniae before and after PCV7 vaccination. Otolaryngol Head Neck Surg. 2015;152:336-341.
30.
TsaiCJGriffinMRNuortiJPGrijalvaCG.Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin Infect Dis. 2008;46:1664-1672.
31.
HsuHEShuttKAMooreMR. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med. 2009;360:244-256.
32.
Centers for Disease Control and Prevention (CDC). National, state, and urban area vaccination coverage among children aged 19-35 months—United States, 2005. MMWR Morb Mortal Wkly Rep. 2006;55:988-993.
33.
American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics. 2004;113:1451-1465.
34.
CocoAVernacchioLHorstMAndersonA.Management of acute otitis media after publication of the 2004 AAP and AAFP clinical practice guideline. Pediatrics. 2010;125:214-220.
35.
HobermanAGreenbergDPParadiseJL. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA. 2003;290:1608-1616.
36.
BlockSLHeikkinenTTobackSLZhengWAmbroseCS.The efficacy of live attenuated influenza vaccine against influenza-associated acute otitis media in children. Pediatr Infect Dis J. 2011;30:203-207.
37.
HeikkinenTBlockSLTobackSLWuXAmbroseCS.Effectiveness of intranasal live attenuated influenza vaccine against all-cause acute otitis media in children. Pediatr Infect Dis J. 2013;32:669-674.
38.
American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for influenza immunization of children. Pediatrics. 2004;113:1441-1447.
39.
American Academy of Pediatrics Committee on Infectious Diseases. Prevention of influenza: recommendations for influenza immunization of children, 2006-2007. Pediatrics. 2007;119:846-851.
40.
American Academy of Pediatrics Committee on Infectious Diseases. Prevention of influenza: recommendations for influenza immunization of children, 2008-2009. Pediatrics. 2008;122:1135-1141.
41.
CohenRLevyCdeLaRocqueF. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media. Pediatr Infect Dis J. 2006;25:1001-1007.
42.
WeinbergerDMMalleyRLipsitchM.Serotype replacement in disease after pneumococcal vaccination. Lancet. 2011;378:1962-1973.
